BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 89 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $482,519 | -0.8% | 26,688 | +10.2% | 0.09% | -10.6% |
| Q3 2023 | $486,379 | -9.4% | 24,210 | +15.0% | 0.10% | -2.8% |
| Q2 2023 | $537,068 | +32.0% | 21,045 | +10.0% | 0.11% | -8.5% |
| Q1 2023 | $406,938 | -43.1% | 19,132 | -20.8% | 0.12% | -83.1% |
| Q4 2022 | $714,751 | -32.7% | 24,147 | -47.1% | 0.69% | -28.9% |
| Q3 2022 | $1,062,000 | +24.1% | 45,667 | -10.5% | 0.98% | +49.8% |
| Q2 2022 | $856,000 | -32.6% | 51,027 | +76.3% | 0.65% | +8.7% |
| Q1 2022 | $1,270,000 | -39.7% | 28,942 | -16.4% | 0.60% | -21.9% |
| Q4 2021 | $2,106,000 | – | 34,600 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |